COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy

Journal of the American Society of Nephrology

Volumn 18, Issue 11, 2007, Pages 3004-3016

  Voskarides, Konstantinos ^a   Damianou, Loukas ^d,g   Neocleous, Vassos ^b   Zouvani, Ioanna ^c   Christodoulidou, Stalo ^d   Hadjiconstantinou, Valsamakis ^d   Ioannou, Kyriacos ^c   Athanasiou, Yiannis ^c   Patsias, Charalampos ^e   Alexopoulos, Efstathios ^f   Pierides, Alkis ^c,h   Kyriacou, Kyriacos ^b   Deltas, Constantinos ^a,b  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^c NICOSIA GENERAL HOSPITAL   (Cyprus)

^d EVANGELISMOS HOSPITAL   (Greece)

^e Larnaca General Hospital   (Cyprus)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^g LIMASSOL GENERAL HOSPITAL   (Cyprus)

^h Ippokrateion Private Hospital   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A;

ADULT; ARTICLE; BASEMENT MEMBRANE; COL4A3 GENE; COL4A4 GENE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOUNDER EFFECT; GENE; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROTEINURIA;

EID: 35848944448     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007040444     Document Type: Article

References (49)

1. Kashtan CE: Alport syndrome and thin basement membrane disease. Curr Diagn Pathol 8: 349-360, 2002
2. Tryggvason K, Patrakka J: Thin basement membrane nephropathy. J Am Soc Nephrol 17: 813-822, 2006
3. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ, et al.: Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8: 77-81, 1994
4. Jefferson JA, Lemmink HH, Hughes AE, Hill CM, Smeets HJ, Doherty CC, Maxwell AP: Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 12: 1595-1599, 1997
5. van der Loop FT, Heidet L, Timmer ED, van den Bosch BJ, Leinonen A, Antignac C, Jefferson JA, Maxwell AP, Monnens LA, Schroder CH, Smeets HJ: Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 58: 1870-1875, 2000
6. Ciccarese M, Casu D, Ki Wong F, Faedda R, Arvidsson S, Tonolo G, Luthman H, Satta A: Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia. Nephrol Dial Transplant 16: 2008-2012, 2001
7. Pescucci C, Mari F, Longo I, Vogiatzi P, Caselli R, Scala E, Abaterusso C, Gusmano R, Seri M, Miglietti N, Bresin E, Renieri A: Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 65: 1598-1603, 2004
8. Lemmink HH, Nillesen WN, Mochizuki T, Schroder CH, Brunner HG, van Oost BA, Monnens LA, Smeets HJ: Benign familial hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 98: 1114-1118, 1996
9. Buzza M, Wang YY, Dagher H, Babon JJ, Cotton RG, Powell H, Dowling J, Savige J: COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome. Kidney Int 60: 480-483, 2001
10. Ozen S, Ertoy D, Heidet L, Cohen-Solal L, Ozen H, Besbas N, Bakkaoglu A, Antignac C: Benign familial hematuria associated with a novel COL4A4 mutation. Pediatr Nephrol 16: 874-877, 2001
11. Badenas C, Praga M, Tazon B, Heidet L, Arrondel C, Armengol A, Andres A, Morales E, Camacho JA, Lens X, Davila S, Mila M, Antignac C, Darnell A, Torra R: Mutations in the COL4A4 and COL4A3 genes cause familial benign hematuria. J Am Soc Nephrol 13: 1248-1254, 2002
12. Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frasca G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M: COL4A3/COL4A4 mutations: From benign familial hematuria to autosomal dominant or recessive Alport syndrome. Kidney Int 61: 1947-1956, 2002
13. Buzza M, Dagher H, Wang YY, Wilson D, Babon JJ, Cotton RG, Savige J: Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int 63: 447-453, 2003
14. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M: Novel COL4A4 splice defect and in-frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndrome. Nephrol Dial Transplant 18: 1122-1127, 2003
15. Tazon Vega B, Badenas C, Ars E, Lens X, Mila M, Darnell A, Torra R: Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases. Am J Kidney Dis 42: 952-959, 2003
16. Wang YY, Rana K, Tonna S, Llin T, Sin L, Savige J: COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN). Kidney Int 65: 786-790, 2004
17. Rana K, Tonna S, Wang YY, Sin L, Lin T, Shaw E, Mookerjee I, Savige J: Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. Pediatr Nephrol 22: 652-657, 2007
18. Slajpah M, Gorinsek B, Berginc G, Vizjak A, Ferluga D, Hvala A, Meglic A, Jaksa I, Furlan P, Gregoric A, Kaplan-Pavlovcic S, Ravnik-Glavac M, Glavac D: Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria. Kidney Int 71: 1287-1295, 2007
19. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY: Thin basement membrane nephropathy. Kidney Int 64: 1169-1178, 2003
20. Kashtan CE: Familial hematurias: What we know and what we don't. Pediatr Nephrol 20: 1027-1035, 2005
21. Gregory MC: The clinical features of thin basement membrane nephropathy. Semin Nephrol 25: 140-145, 2005
22. Wang YY, Savige J: The epidemiology of thin basement membrane nephropathy. Semin Nephrol 25: 136-139, 2005
23. Torra R, Tazon-Vega B, Ars E, Ballarin J: Collagen type IV (alpha3-alpha4) nephropathy: From isolated haematuria to renal failure. Nephrol Dial Transplant 19: 2429-2432, 2004
24. Rana K, Wang YY, Buzza M, Tonna S, Zhang KW, Lin T, Sin L, Padavarat S, Savige J: The genetics of thin basement membrane nephropathy. Semin Nephrol 25: 163-170, 2005
25. Nieuwhof CMG, de Heer F, de Leeuw P, van Breda Vriesman PJC: Thin GBM nephropathy: Premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 51: 1596-1601, 1997
26. Nogueira M, Cartwright J Jr, Horn K, Doe N, Shappell S, Barrios R, Coroneos E, Truong LD: Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation. Am J Kidney Dis 35: E15, 2000
27. Norby SM, Cosio FG: Thin basement membrane nephropathy associated with other glomerular diseases. Semin Nephrol 25: 176-179, 2005
28. Marquez B, Stavrou F, Zouvani I, Anastasiades E, Patsias C, Pierides A, Kyriacou K: Thin glomerular basement membranes in patients with hematuria and minimal change disease. Ultrastruct Pathol 23: 149-156, 1999
29. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251-256, 2000
30. Weins A, Kenlan P, Herbert S, Le TC, Villegas I, Kaplan BS, Appel GB, Pollak MR: Mutational and biological analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. J Am Soc Nephrol 16: 3694-3701, 2005
31. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB: A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308: 1801-1804, 2005
32. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR: TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37: 739-744, 2005
33. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS: CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298-1300, 2003
34. Ihalmo P, Palmen T, Ahola H, Valtonen E, Holthofer H: Filtrin is a novel member of nephrin-like proteins. Biochem Biophys Res Commun 300: 364-370, 2003
35. Srichai MB, Konieczkowski M, Padiyar A, Konieczkowski DJ, Mukherjee A, Hayden PS, Kamat S, El-Meanawy MA, Khan S, Mundel P, Lee SB, Bruggeman LA, Schelling JR, Sedor JR: A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus. J Biol Chem 279: 14398-14408, 2004
36. Yiallouros P, Neocleous V, Zeniou M, Adamidou T, Costi C, Christophi C, Tzetis M, Kanavakis E, Deltas C: Cystic fibrosis mutational spectrum and genotypic/phenotypic features in Greek-Cypriots, with emphasis on dehydration as presenting symptom. Clin Genet 71: 290-292, 2007
37. Demetriou K, Tziakouri C, Anninou K, Eleftheriou A, Koptides M, Nicolaou A, Deltas CC, Pierides A: Autosomal dominant polycystic kidney disease-type 2: Ultrasound, genetic and clinical correlations. Nephrol Dial Transplant 15: 205-211, 2000
38. Deltas C: Inherited diseases and Cyprus reality: A historico-genetic approach. In: 30th Annals of the Cyprus Research Center (Epetirida), edited by the Ministry of Education and Culture, Nicosia, Cyprus, Ministry of Education and Culture, 2004:457-489.
39. Heidet L, Arrondel C, Forestier L, Cohen-Solal L, Mollet G, Gutierrez B, Stavrou C, Gubler MC, Antignac C: Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 12: 97-106, 2001
40. Boye E, Mollet G, Forestier L, Cohen-Solal L, Heidet L, Cochat P, Grunfeld JP, Palcoux JB, Gubler MC, Antignac C: Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet 63: 1329-1340, 1998
41. Sue Y-M, Huang J-J, Hsieh R-Y, Chen F-F: Clinical features of thin basement membrane disease and associated glomerulopathies. Nephrology 9: 14-18, 2004
42. van Paasen P, van Breda Vriesman PJ, van Rie H, Tervaert JW: Signs and symptoms of thin basement membrane nephropathy: A prospective regional study on primary glomerular disease - The Limburg Renal Registry. Kidney Int 66: 909-913, 2004
43. Haas M: Thin glomerular basement membrane nephropathy: Incidence in 3471 consecutive renal biopsies examined by electron microscopy. Arch Pathol Lab Med 130: 699-706, 2006
44. Stavrou C, Koptides M, Tombazos C, Psara E, Patsias C, Zouvani I, Kyriacou K, Hildebrandt F, Christofides T, Pierides A, Deltas CC: Autosomal-dominant medullary cystic kidney disease type 1: Clinical and molecular findings in six large Cypriot families. Kidney Int 62: 1385-1394, 2002
45. Beirowski B, Weber M, Gross O: Chronic renal failure and shortened lifespan in Col4a3+/- mice: An animal model for thin basement membrane nephropathy. J Am Soc Nephrol 17: 1986-1994, 2006
46. Marquez B, Zouvani I, Karagrigoriou A, Anastasiades E, Pierides A, Kyriacou K: A simplified method for measuring the thickness of glomerular basement membranes. Ultrastruct Pathol 27: 409-416, 2003
47. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988
48. Lathrop GP, Lalouel JM, Julier C, Ott J: Multilocus linkage analysis in humans: Detection of linkage and estimation of recombination. Am J Hum Genet 37: 482-498, 1985
49. Oleykowski CA, Mullins CRB, Godwin AK, Yeung AT: Mutation detection using a novel plant endonuclease. Nucleic Acids Res 26: 4597-4602, 1998